abnormal lymph node morphology_Tg(CAG-PGDS)1Groy/0

http://metadb.riken.jp/0002339IFVBNTgCAGPGDS1Groy0TgCAGPGDS1Groy

abnormal lymph node morphology_Tg(CAG-PGDS)1Groy/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 1, Derek W Gilroy
  http://metadb.riken.jp/db/mgi_rdf/MGI:3624139

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(CAG-PGDS)1Groy/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(CAG-PGDS)1Groy

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: FVB/N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal lymph node morphology
  http://purl.obolibrary.org/obo/MP_0002339

文献

http://purl.org/net/cito/citesAsAuthority

• Seema G. Trivedi, et.al., Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity., Proceedings of the National Academy of Sciences of the United States of America, 2006, 103
  http://rdf.ncbi.nlm.nih.gov/pubmed/16547141